Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic factors associated with treatment response to reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy.

Molecular vision - 1 Jan 2020

Hayashida Mayuka, Miki Akiko, Nakai Shunichiro, Matsumiya Wataru, Imai Hisanori, Kusuhara Sentaro, Honda Shigeru, Nakamura Makoto

Abstract excerpt

Purpose: Reduced-fluence photodynamic therapy (RFPDT) has proven effective for some patients with chronic central serous chorioretinopathy (cCSC). Several clinicodemographic factors influencing treatment response have been identified, but associations with genetic factors have not been examined. Therefore, we investigated the associations of single nucleotide polymorphisms (SNPs) implicated in cCSC pathogenesis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Chronic Disease
Share to Coloring Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Complement Factor H

Share to Fluorescein Angiography

Share to Gene-Environment Interaction

Share to Photochemotherapy

Share to Photosensitizing Agents

Share to Visual Acuity

Source

Open in PubMed Open full text

Identifiers

PMID: 32774081
PMCID: PMC7378327

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic factors associated with treatment response to reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy.PMID 32774081Read ↗

Role of the Complement System in Chronic Central Serous Chorioretinopathy: A Genome-Wide Association Study.Semantic proximity Read ↗

Genetic associations of central serous chorioretinopathy: a systematic review and meta-analysis.Semantic proximity Read ↗

GENETIC RISK FACTORS IN SEVERE, NONSEVERE AND ACUTE PHENOTYPES OF CENTRAL SEROUS CHORIORETINOPATHY.Semantic proximity Read ↗

Chronic central serous chorioretinopathy is associated with genetic variants implicated in age-related macular degeneration.Semantic proximity Read ↗

Association between CFH single nucleotide polymorphisms and response to photodynamic therapy in patients with central serous chorioretinopathy.Semantic proximity Read ↗

Association of central serous chorioretinopathy with single nucleotide polymorphisms in complement factor H gene in Iranian population.Semantic proximity Read ↗

Associations of Single-Nucleotide Polymorphisms in Slovenian Patients with Acute Central Serous Chorioretinopathy.Semantic proximity Read ↗

Complement factor H Y402H and C-reactive protein polymorphism and photodynamic therapy response in age-related macular degeneration.Semantic proximity Read ↗

CHOROIDAL VASCULARITY IN CHRONIC CENTRAL SEROUS CHORIORETINOPATHY AND ITS ASSOCIATION WITH RISK SINGLE-NUCLEOTIDE POLYMORPHISMS.Semantic proximity Read ↗

Multi-Polymorphism Analysis Reveals Joint Effects in Males With Chronic Central Serous Chorioretinopathy.Semantic proximity Read ↗

Panmacular Micropulse Laser Treatment of Central Serous Chorioretinopathy: Two-Year Follow-Up of Morphological and Functional ParametersSemantic proximity Read ↗

Photodynamic therapy in VEGF inhibition non-responders-Pharmacogenetic study in age-related macular degeneration assessed with swept-source optical coherence tomography.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.